fig1
Figure 1. Prevention and treatment of AILD recurrence post LT. AZA: Azathioprine; IBD: inflammatory bowel disease; MMF: mycophenolate mofetil; OCA: obeticholic acid; UDCA: ursodeoxycholic acid.
Figure 1. Prevention and treatment of AILD recurrence post LT. AZA: Azathioprine; IBD: inflammatory bowel disease; MMF: mycophenolate mofetil; OCA: obeticholic acid; UDCA: ursodeoxycholic acid.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/